- Home
- LVO vs VNRX Comparison
LVO vs VNRX Comparison
Compare LVO & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LVO | VNRX |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.1M | 38.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LVO | VNRX |
|---|---|---|
| Price | $4.29 | $0.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $13.00 | $2.50 |
| AVG Volume (30 Days) | 87.9K | ★ 2.2M |
| Earning Date | 02-12-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $86,702,000.00 | $1,472,007.00 |
| Revenue This Year | N/A | $55.98 |
| Revenue Next Year | $29.74 | $420.37 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.48 |
| 52 Week Low | $3.70 | $0.22 |
| 52 Week High | $16.00 | $0.94 |
Technical Indicators
Market Signals| Indicator | LVO | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.24 | 47.78 |
| Support Level | $3.80 | $0.31 |
| Resistance Level | $4.60 | $0.39 |
| Average True Range (ATR) | 0.38 | 0.03 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 55.66 | 41.70 |
Price Performance
Historical ComparisonAbout LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.